Outpatient Oncology Infusion Market - Top Companies and Manufacturers

Companies Dominating the Outpatient Oncology Infusion Landscape

Numerous important companies in the outpatient oncology infusion market are starting several tactical projects to increase their market share and strengthen their positions in the industry. It is predicted that the top five companies will control the majority of the outpatient oncology infusion market share by taking calculated risks, expanding, forming agreements, and participating in joint ventures.

Baxter International Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

B. Braun Melsungen AG
Becton, Dickinson and Company
Fresenius Kabi
ICU Medical, Inc
IRadimed Corporation
Teleflex Medical Pvt. Ltd.
Smiths Medical, Inc.
Medtronic plc

Browse Key Market Insights with Data Illustration:

Outpatient Oncology Infusion Market Size, Forecast Report 2036

In the News

In June 2023, B. Braun Melsungen AG introduced the next generation of infusion management software, DoseTrac Enterprise Infusion Management Software that enables users to control their infusion pumps from a single, central application, and can contribute to better data management, which might reduce the need for clinical IT infrastructure related to infusion pumps.
In August 2023, ICU Medical Inc., a global leader in medical device development and sales, has received 510(k) regulatory clearance from the FDA for the Plum Duo infusion pump with LifeShield infusion safety software.

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of outpatient oncology infusion was over USD 79.1 billion.

The market size for outpatient oncology infusion is projected to cross USD 266.7 billion by the end of 2036 expanding at a CAGR of 11.5% during the forecast period i.e., between 2024-2036.

The major players in the market are B. Braun Melsungen AG, Becton, Dickinson and Company, Fresenius Kabi, ICU Medical, Inc., IRadimed Corporation, Teleflex Medical Pvt. Ltd., Smiths Medical, Inc., Medtronic plc, and others.

In terms of product, the infusion pumps segment is anticipated to account for the largest market share of 51.1% during 2024-2036.

The North America outpatient oncology infusion market is poised to hold the highest share of 37.5% by 2036.

Outpatient Oncology Infusion Market - Top Companies and Manufacturers

Companies Dominating the Outpatient Oncology Infusion Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the outpatient oncology infusion industry?

What is the outlook for the outpatient oncology infusion market?

Who are the major players dominating the outpatient oncology infusion landscape?

Which product segment captures the significant market share for outpatient oncology infusion by 2036?

Which region will provide more opportunities for the outpatient oncology infusion business in near future?